deeptech Value proposition
Making high-value glycans mainstream.
eversyn is a spin-off of the Max Planck Institute Magdeburg - run, founded and supported by current and former Max Planck scientists and business professionals. Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.
Synthetic Glycobiotechnology, Glycobiotechnology, Biotechnology, Oligosaccharides, Nucleotide Sugars, In Vitro Glycoengineering, HMOs, and activated sugars
eversyn | bioactive sugars for nutrition & biopharma
eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.
https://www.eversyn.de/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Plug and Play Tech Center Startup accelerator & VC, Venture Capital and Private Equity Principals | Plug and Play Tech Center Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 7 Jul 2024 | | |
 Bayer Chemistry, Pharmaceutical, Chemical Manufacturing | Bayer Chemistry, Pharmaceutical, Chemical Manufacturing | Other 31 Dec 2023 | | |